Eight insiders at Electra Therapeutics, Inc. (ETRA) have made significant purchases of the company's stock, totaling approximately $80 million. The transactions occurred on September 23, 2026, with individual purchases ranging from $5 million to $15 million per insider.
The buying activity was led by entities associated with OrbiMed, including Advisors Llc Orbimed, Capital Gp Vii Llc Orbimed, and Genesis Gp Llc Orbimed, with directors Carl L. Gordon also participating. Each of these individuals and entities acquired shares at a price of $15.00 per share.
This concentrated insider buying, involving multiple directors and 10% owners purchasing shares around the same time, is often viewed as a strong bullish signal by market observers, suggesting confidence in the company's future prospects.